Special Safe Harbor non-pharm conference
issue
Lead story:
A speedy traverse of integrative psychiatry.
Also in this issue:
Procovery, Hyperbaric chambers, Toxins, Native American
view, Abilify, Double trouble, Omega-3, Vagus nerve
stimulation, Antipsychotics and diabetes, Better than
Haldol?, Paxil for Hot Flashes, SSRI open season in the
UK, Personality types, Jail diversion, Truehope sues
Health Canada, Teen sex, Right to refuse meds, Lilly
Reintegration Awards, Boston Tea Party, Food for thought,
Next issue, McMan's Web, Donation information.
Anything Goes?
Tricia’s
adopted son - we’ll call him Andrew - started to unravel
at age eight. "It was the scariest thing to happen to a
mother," she recalled. Andrew threw things, flew into
rages, and jumped out of a van at 50 miles an hour. Andrew
was diagnosed with bipolar I and put on meds, but
according to his mother he became a vegetable, sleeping
all the time and not engaging in the outdoor activities he
once loved. Whereas Andrew had once tested four to six
years above grade level, he was now testing two years
below. As Tricia explained: "They felt they had solved my
problem. I felt I lost my child."
In
desperation, she weaned her child off his meds and started
him on a regimen of vitamins and supplements. This nearly
resulted in Andrew getting kicked out of school, but she
stayed the course and was happy to report that her son had
just been awarded the most joyful kid in his class.
Tricia was
speaking at a two-day conference, Non-Pharmaceutical
Approaches to Mental Disorders staged in Pasadena May
31-June 1 by a nonprofit organization,
Safe Harbor. The need for such a conference can best
be underscored by contrasting it to the six-day American
Psychiatric Association’s annual meeting which took place
two weeks earlier in San Francisco. That conference
featured hundreds of workshops and symposia, many
underwritten by pharmaceutical companies, with just one
session (to this writer’s knowledge) on vitamins and
supplements.
Fortunately,
mainstream psychiatry and alternative therapies don’t have
to be either-or choices. As Lewis Mehl-Madrona MD, PhD of
the University of Arizona, a half Cherokee raised in
tribal shaman traditions and author of Coyote Medicine and
Coyote Healing, told the Safe Harbor conference, "whatever
works is good medicine." He has coined the term,
integrative psychiatry, to describe the combined
medical-alternative approach he is implementing at the
University of Arizona.
Many of the
leading so-called alternative practitioners are
firmly-grounded in western medicine. The patients who find
their way to the Pfeiffer clinic in Illinois, for example,
are given an extensive battery of tests to determine body
toxins and nutrient deficiencies and how the body
methylates substances prior to the formulation of a
treatment plan based on diet and supplements. And Gunnar
Heuser MD, PhD of UCLA is as western as they come, a
neurotoxicologist who happened to acquire a hyperbaric
chamber. Not only is the treatment hi-tech, but he sends
his patients for before and after brain scans.
On the flip
side of the coin, simply by prescribing lithium to their
bipolar patients, most psychiatrists are already engaged
in "natural" treatment. Omega-3 is making headway in many
practices, and there is sure to be something growing by
the side of the road that will one day be met with equal
enthusiasm. In the meantime, shamanism lives. When this
writer asked a number of psychiatrists at the APA meeting
what they found worked best in treating patients with
bipolar, several of them replied establishing a trusting
relationship with the patient. Getting the patient to buy
into one’s treatment (and by extension healthy lifestyle
choices), in other words, dramatically enhances one’s
chances of recovery, whether it is medication we are
talking about or acupuncture.
Hopefully,
the day will come when people like Tricia can turn to
their psychiatrists for expert care on natural supplements
and diet as well as meds. Fortunately, Tricia’s son turned
out fine. What we didn’t hear about at the Safe Harbor
conference were the patients who tried the same thing and
wound up in the hospital, case studies for what happens
when people go off their meds but also an indictment on a
profession that knows more about Seroquel than vitamin C.
Last month, the APA turned down a proposal for a research
task force for unconventional therapy. The good news is
that the proposal was entertained in the first place. All
in good time ...
Safe Harbor
More on the
Safe Harbor conference ...
Procovery
A deep
needle biopsy that struck the sciatic nerve was part of
Kathleen Crowley’s descent into pain and madness,
recounted in her book, The Day Room. The intense chronic
pain is still with her and will always be. What changed
was when an insightful doctor prompted her into the
revelation that she could never go backward - to how she
had been before - but that she could move ahead. Hence the
title of her latest book, The Power of Procovery.
Kathleen
told the Safe Harbor conference that procovery is about
attaining a productive and fulfilling life, regardless of
the limitations of symptoms. As she explains on her
website:
"The fundamental focus of procovery is one of moving
forward when you can no longer move back, of letting go of
what was and rebuilding new dreams."
Part of the
process involves the recognition that big problems don’t
necessarily require big solutions. "Small changes," she
says, "can have big impact." Another important rule is
"just start anywhere." Where do we start? is a proposition
that tends to immobilize us. "Whether it’s number one or
number five or number 30 on the task list," she advises,
"whether it’s getting a goldfish or getting a job, just
start anywhere."
Air Power
Gunnar
Heuser MD, PhD of UCLA, referred to in passing in the lead
article, has yet to treat patients with depression or
bipolar, but his work using a hyperbaric chamber on those
exposed to neurotoxins, including several who manifested
ADD, may be the beginning of a trend. Hyperbaric chambers
contain compressed air, and are essential for deep-ocean
divers to avoid getting the bends. Mountaineers use
pump-inflated portable chambers to cope with
oxygen-depletion at high altitudes. The high air pressure
inside the chamber forces more oxygen into the body’s
blood and tissues. Most hyperbaric chambers operate at two
or three times normal atmospheric pressure, but Dr Heuser
uses a smaller chamber at 1.3 times normal atmospheric
pressure, with 24 percent oxygen concentration. Patients
are typically given 10 one-hour treatments.
Of 10
patients he treated for toxic encephalopathy (which
results in cognitive and memory impairment), eight showed
significant improvement and two marginal improvement in
TOVA scores. Before and after SPECT imaging showed marked
reduction in blue and violet areas -signifying a return of
more normal blood flow - in the brain.
Toxins
Nancy Mullan
MD, who practices psychiatry in LA, talked about the rain
barrel effect that occurs when a person is exposed to one
toxin too many, resulting in an overflow that can
overwhelm victims. An excerpt from a video she showed,
Doris Rapp MD’s Environmentally Sick Schools, documented
the various molds, dust, chemicals, pollens, and foods
that can turn healthy individuals into physical and mental
basket cases.
The small
intestine, Dr Mullan told the Safe Harbor conference, is
the loci for most food reactions. If the intestinal wall
protrusions called the villi are damaged, then we have
trouble absorbing food. What contributes to their damage
includes non-steroid anti-inflammation drugs, HIV,
parasites, alcohol, aging, and ingesting allergic foods.
Dr Mullan
often has her patients take food allergy tests, though
they are expensive and their reliability has been called
into question. A more labored but failsafe means, she
says, would be to eliminate a suspect food from one’s diet
to see what happens. These would include: dairy, wheat,
corn, eggs, citrus, caffeine, alcohol, refined sugar,
honey, maple or barley syrup, tap water, or any food one
eats more than three times a week.
In the
meantime, she advised, read labels carefully, as hidden
allergens are frequently found in packaged foods.
A Native American View
Lewis
Mehl-Madrona MD, PhD, mentioned in the lead article,
referred to the Cree Indian medicine wheel as an example
of how native cultures can inform the west:
One first
goes to the east, Dr Mehl-Madrona explained, to connect
the person with the spirit, followed by the south for
feelings, then the west for body and the north for beliefs
and values. Three more circuits are made of the wheel to
connect the person to his or her surroundings and
community, to instill a sense of identity, and finally to
become a teacher and advocate.
Dr
Mehl-Madrona is working on a study that will randomize
patients into the full gamut of alternative therapies on
the hypothesis that people will get better regardless of
the type of treatment, that their relationship to their
healer and their belief in getting better will play key
roles. He cited his own study of Reiki on asthma patients
whose results were simply too good to be believed. "We
didn’t do a study of Reiki," he told the Safe Harbor
conference. "We did a study of the culture of Reiki,"
which began in the waiting room, where people met and were
introduced to new friends and new therapies and lifestyle
choices.
Even in the
psychiatric literature, he stated, we know the drug is not
responsible for the total effect.
In the
Cherokee view, he related, anything you do changes your
chemistry. Watching horror movies, he said, down-regulates
cytokines (involved in the immune system) while watching
the Marx Brothers up-regulates cytokines within 15
minutes.
"Whatever
the ceremony," he concluded, using the term in a
therapeutic sense, "I am bigger than I thought I was, I
can expect more from myself."
Segue
Much more on
the Safe Harbor conference in future issues. Now to
several items from last month’s APA meeting ...
Abilify
At May's APA
meeting, Bristol-Myers Squibb released a new study on
Abilify for acute mania. In two previous trials, one study
failed while the other showed 40 percent of patients
responding. This time, a 12-week trial involving 347
patients found that 50 percent of them responded and
remained on Abilify vs 28 percent who took Haldol.
Thirty-six percent of the Haldol patients reported EPS
(muscle movement effects) vs nine percent on Abilify.
Double Trouble
A UCLA study
released at the APA meeting of 11 bipolar patients who
reported drinking 14 days in the previous month found they
consumed an average of 11 drinks a day. At a symposium at
the APA, one of the study’s co-authors, Mark Frye MD,
reported that according to Epidemiological Catchment Area
study, 60.7 percent of bipolar patients have a lifetime
substance dependency, with 46.2 percent of bipolar I
patients and 39.2 percent of bipolar II patients having a
lifetime alcohol dependency.
Meanwhile,
at the APA meeting, a Case Western reserve study of 73
rapid-cyclers (equally divided between male and female)
with a recent history of substance dependence found that
45 percent had been convicted of a serious offense and 62
percent had been charged with misdemeanors. Of the 34
percent who had been jailed, 70 percent were males.
Omega-3
An NIH study
unveiled at May’s APA meeting tracking 14,541 women from
their eighth week of pregnancy to eight months after
giving birth found those who had no seafood - rich in
omega-3 - had nearly twice the rate of depression as those
who ate 10 ounces of fish daily, leading the authors to
conclude: "Omega-3 fatty acids have beneficial health
effects with no adverse side effects."
Antipsychotics and Diabetes
Newsletter
5#11 reported on studies by Elizabeth Koller MD, a former
FDA official, and P Murali Doraiswamy MD of Duke that
suggest a link between Zyprexa, Risperdal, and Clozaril
and diabetes. At the APA meeting, the two authors unveiled
a study from the FDA database that fingered Seroquel,
involving 34 patients with newly-diagnosed hyperglycemia.
There were 21 cases of diabetic ketoacidosis resulting in
11 deaths.
Meanwhile,
at the same venue, Eli Lilly released an analysis of
previous trials that found approximately one-third of the
patients had pre-existing high glucose levels and that
two-thirds possessed multiple risk factors for diabetes.
Weight gain had only minimal impact on diabetes onset.
Segue
And now back
to regular programming ...
Vagus Nerve Stimulation
Cyberonics
has announced the completion of a 12-month study of
treatment-refractory depressed patients involving placing
a pacemaker-like device in the chest that delivers pulses
through a wire to the vagus nerve and into the brain.
Among the completers, the response rate was 31 percent.
Better Than Haldol?
A feature
article in the NY Times reports on three studies that
suggest atypical antipsychotics may only be marginally
more effective than the older generation antipsychotics
such as Haldol. A University of Illinois at Chicago
analysis of 124 studies released a month ago found
Clozaril the most effective, followed by Risperdal and
Zyprexa, but the rest conferred no advantage. A 2000
Oxford analysis of 52 studies published in the British
Medical Journal found no difference in effectiveness
between the newer and older drugs. And a German review
published recently in The Lancet (see Newsletter5#14)
found only Clozaril had fewer side effects than the older
drugs.
Sales of
atypical antipsychotics in the US reached $5.4 million in
2002, putting them fourth behind cholesterol drugs, ulcer
drugs, and antidepressants. More than 7.4million
prescriptions were written for Zyprexa and more than 7.6
million for Risperdal.
Hot Flashes
A Johns
Hopkins
study of 165 menopausal women found those receiving
12.5 mg of Paxil reduced their daily hot flashes from 7.1
to 3.8 and 6.4 to 3.2 for the 25 mg group vs 6.6 to 4.8
for those on a placebo.
HealthScout reports that Paxil is not as effective as
hormone replacement therapy, which can reduce hot flash
frequency by up to 90 percent, but may be a safer
alternative.
Bad Press
It’s open
season on SSRIs in the UK. The Independent reports on a
high-profile coroner’s inquest into the death of Wendy
Hay, 52, who hanged herself while on Prozac. David Healy
MD of the University of Wales, who has testified as an
expert witness in cases involving Prozac and Paxil, told
the inquest: "This drug can make healthy people who aren’t
remotely thinking of suicide suicidal."
Manufacturer
Eli Lilly has issued a statement saying: "There is no
credible scientific evidence that establishes a causal
connection between Prozac and violent or suicidal
behavior."
Meanwhile,
the BBC news magazine program,
Panorama, last month aired a sequel to last October’s
piece on the withdrawal effects of Paxil (marketed as
Seroxat in the UK). That program resulted in 67,000 phone
calls and nearly 1,400 emails. Said one viewer: "It was
strange to learn from a TV program rather than your GP
what these side effects were."
Personality Types
Newsletter
5#14 reported on a reader poll that found a surprising 83
percent who replied were introverts, leading this writer
to speculate on how our illness may isolate us. Since
publishing that piece, David Janowsky MD of the University
of North Carolina sent me several articles of studies he
has published in this area, which drive home the point
with considerable force. One of his studies turned up 74
percent introverts among a depressed population and
another found 84 percent introverts among those who were
suicidal, leading him and his co-authors to observe:
"The issue of social isolation has been mentioned as a
potential risk factor for suicidality. The introverted
individual almost certainly has trouble reaching out to
others, especially in times of stress and need. Thus the
social isolation of introversion may set the scene for
suicidality."
In another article, Dr Janowski commented: "Increased
introversion predicts the persistence of depressive
symptoms and a lack of remission."
Your Opinion
Should
psychiatrists and therapists use a shortened form of the
Myers-Briggs to screen for introverts? Email
mcman@mcmanweb.com and feel free to addd your own
insights. Confidentiality assured.
Jail Diversion
The Mentally
Ill Offender Treatment and Crime Reduction Act of 2003
that would authorize $100 million to create jail diversion
programs for the mentally ill, provide treatment to those
who are incarcerated, and establish services to those
returning to the community is before both houses of the US
Congress. NAMI is urging people to contact their
legislators and request they co-sponsor either the Senate
version (S 1194) or the House version (HR 2387) of the
bill.
Border Dispute
Alberta-based Truehope, makers of Empowerplus supplements
for treating bipolar and other illnesses, is suing Health
Canada for stopping shipments at the border. The
manufacturing of the supplement has been contracted to a
US company, which means hundreds of Canadians have been
cut off. According to David Hardy, cofounder of Truehope:
"We're getting calls from desperate people. They can't go
back to medication. The conventional meds don't work for
many people."
In Dec 2001,
a University of Calgary open trial of 14 bipolar patients
still on their meds while taking the supplement found that
depression scores dropped by 55 percent after 44 weeks and
mania scores by 66 percent. That study was published in
the Journal of Clinical Psychiatry, which also carried a
commentary by Charles Popper MD of Harvard, who reported
successfully treating 19 of 22 bipolar patients with the
supplement.
Teen Sex
The
conservative think tank, the Heritage Foundation, has
released a
study that found that 25 percent of sexually active
teens say they are depressed all or a lot of the time vs
eight percent of girls who are not sexually active. About
14 percent of girls who had intercourse have attempted
suicide vs five percent of girls who had not. Six percent
of sexually active boys attempted suicide vs less than one
percent sexually inactive boys.
Pyrrhic Victory
The Canadian
Supreme Court has ruled 6-3 that Scott Starson, 47, is
entitled to refuse the antipsychotic meds his doctors want
to give him. Despite no formal training, Scott has
published academic articles on anti-gravity, relativity,
and similar topics. Five years ago, he was hospitalized
after a court found him not criminally responsible for
making death threats. Release back into the community is
not foreseeable for Scott, who believes the Pope is in his
employ. Said his mother to
CBC News: "I'm devastated and I truthfully believe
that the Supreme Court did not have sufficient
information. It's the end of his life."
Reintegration Awards
Eli Lilly is
seeking applications for its Reintegration Awards. The
three awards for people living with bipolar or
schizophrenia include: The Artistic Achievement Award, the
Mentorship Award, and The Inspiration Award. First place
winners will receive $5,000 and second place winners
$2,500. Deadline July 25. For more information:
http://www.reintegration.com
Boston Tea Party
The Boston
Globe reports that Massachusetts has scrapped a plan that
would have severely restricted more than 50,000 Medicaid
patients in their choice of antipsychotic meds. The
restrictions would have come into effect last week. "The
impact of destabilizing a person on these drugs is going
to be far more drastic than taking someone off of their
ulcer medication,'' said Dr. David Osser MD, a
psychiatrist on a committee set up to study the matter.
The state still has restrictions for antidepressants,
which went in place in May.
Food for Thought
"Now, when
we should be so excited because we can diagnose mental
illnesses and treat them effectively, the states are
cutting back services. It's really tragic."
Rosalynn
Carter on Larry King Live, which devoted an entire program
to depression on May 28.
Next Issue
It’s back to
mainstream psychiatry and the Fifth International
Conference on Bipolar Disorder, which takes place in
Pittsburgh later this week. Stay tuned for exclusive
reports.
McMan's Web
I've given my website a complete makeover, featuring a
cleaner look and easier navigation. Check out more than
250 articles on all aspects of depression and bipolar,
plus a bookstore, readers' forum, message boards, and
other features at:
http://www.mcmanweb.com
New:
Taking it Personally, an expanded treatment of the
personality types survey that appeared in Newsletter
5#14..
You can
support this Newsletter by clicking on any of the site's
Amazon.com links to do your online buying, including items
not listed on McMan.
Donations
All renewals
and subscriptions have been suspended, with no obligation
to pay. If you would like to support this Newsletter, you
can donate any amount you choose
by credit card
online at:
http://mcmanweb.com/newsletter1.htm
... or by
clicking on the PayPal button below:
Or
you can mail your check to:
McMan's Weekly
PO Box 331
Southington, CT 06489
USA
Please be sure to include your email address on your
check.
By
way of guidance, old rates ran from $10 hardship to $29
regular, with some individuals contributing more, to $100
group rates. In the event I should reinstitute normal
subscriptions and renewals, your donation will count as a
subscription/renewal in full.
For change of address, email
mcman@mcmanweb.com
with both your old and new email addresses.
For free sample issues, email
mcman@mcmanweb.com
and put "Sample" in the heading and your email address in
the body.
Those who do
not have a home computer or cannot open a Hotmail account
may request "depression" and "bipolar" be deleted from the
heading. Email
mcman@mcmanweb.com
and put "Private" in the heading and your email address in
the body.
To
unsubscribe,
email
mcman@mcmanweb.com
and put "Unsubscribe" and your email address in the body.
John McManamy
"Knowledge is necessity."
Copyright
2003 John McManamy